Valacyclovir-Associated Taste Disturbance

Clinical Considerations

The Centers for Disease Control and Prevention recommends valacyclovir dosing regimens for herpes simplex virus infections, including 500 mg twice daily for 5 days for episodic treatment, or 500-1000 mg once daily for suppressive therapy 1
The standard dosing regimen for herpes labialis is 2 g twice daily for 1 day, with most adverse effects at standard doses being mild and including headache, nausea, and diarrhea 2
Taste disturbances may occur alongside common side effects, according to the Centers for Disease Control and Prevention 1

For patients experiencing taste disturbances, ensuring adequate hydration while taking valacyclovir may help minimize side effects, as suggested by clinical guidelines 3
The Journal of Clinical Virology recommends considering whether the clinical benefit outweighs the side effect of taste disturbance, especially for short-course therapy 2
For patients requiring long-term suppressive therapy with significant taste disturbances, alternative antivirals might be considered, according to the Journal of Infection 4

Patients with renal impairment may require dose adjustment of valacyclovir and may be more susceptible to side effects due to decreased drug clearance, as noted in clinical guidelines 3
Immunocompromised patients often require higher doses of valacyclovir and may experience more pronounced side effects, including taste disturbances, as reported by clinical guidelines 5

The Journal of Clinical Virology suggests that for most patients, the therapeutic benefits of valacyclovir outweigh the potential for taste disturbance, especially for short-course therapy 2
If taste disturbance is severe, consider alternative antiviral options after completing the current course of treatment, as recommended by the Journal of Infection 4
The American Academy of Ophthalmology recommends documenting taste disturbances in the patient's medical record to guide future antiviral selection 6